After confirmation of [68Ga]-PSMA-617 brain tumor uptake in PET/CT, Wei et al. treated 2 patients with castration-resistant prostate cancer (CRPC) patients with cerebral metastasis with 3–4 cycles of [177Lu]-PSMA-617, combined with local radiotherapy. Here, FOLH1 is linked to brain neoplasm.